Oak Street Health, Inc.
OSH · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $2,161 | $1,433 | $883 | $557 |
| % Growth | 50.8% | 62.3% | 58.6% | – |
| Cost of Goods Sold | $2,083 | $1,403 | $805 | $527 |
| Gross Profit | $78 | $30 | $77 | $30 |
| % Margin | 3.6% | 2.1% | 8.8% | 5.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $345 | $307 | $185 | $80 |
| SG&A Expenses | $509 | $426 | $250 | $126 |
| Sales & Mktg Exp. | $164 | $119 | $64 | $46 |
| Other Operating Expenses | $35 | $18 | $11 | $8 |
| Operating Expenses | $544 | $444 | $261 | $134 |
| Operating Income | -$466 | -$414 | -$184 | -$104 |
| % Margin | -21.6% | -28.9% | -20.8% | -18.7% |
| Other Income/Exp. Net | -$43 | -$3 | -$9 | -$6 |
| Pre-Tax Income | -$510 | -$417 | -$192 | -$109 |
| Tax Expense | $0 | -$2 | $5 | $4 |
| Net Income | -$510 | -$415 | -$197 | -$114 |
| % Margin | -23.6% | -28.9% | -22.3% | -20.4% |
| EPS | -2.21 | -1.86 | -0.9 | -0.56 |
| % Growth | -18.8% | -106.7% | -60.7% | – |
| EPS Diluted | -2.21 | -1.86 | -0.9 | -0.56 |
| Weighted Avg Shares Out | 230 | 223 | 219 | 204 |
| Weighted Avg Shares Out Dil | 230 | 223 | 219 | 204 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $3 | $9 | $6 |
| Depreciation & Amortization | -$6 | $18 | $11 | $8 |
| EBITDA | -$472 | -$396 | -$172 | -$96 |
| % Margin | -21.8% | -27.7% | -19.5% | -17.2% |